Table 5:
Dependent Variable Evaluated in Model | Model Type | n | Independent Variable | Estimate | p-value |
---|---|---|---|---|---|
| |||||
Beta 95% CI) | |||||
Number of rheumatologist visits in past year | Poisson regression | 122 patients | Age, linear | −0.002 (−0.012, 0.009) | 0.73 |
Male sex | 0.01 (−0.357, 0.379) | 0.95 | |||
Telemedicine group | −0.02 (−0.293,0.249) | 0.87 | |||
Number of visits in year prior to study | 0.11 (0.016, 0.201) | 0.02 | |||
Odds ratio (95% CI) | |||||
Documentation of disease activity at the visit | Multivariate logistic regression | 217 visits | Age, linear | 0.99 (0.97,1.02) | 0.66 |
Male sex | 0.52 (0.21,1.30) | 0.16 | |||
Telemedicine group | 0.54 (0.29,1.02) | 0.06 | |||
RAPID3 at baseline | 0.89 (0.83,0.95) | 0.0004* | |||
Number of visits in year prior to study | 0.76 (0.60,0.97) | 0.02 | |||
Change in medications is prescribed when disease activity is moderate or high | Multivariate logistic regression | 46 visits | Age (linear) | 1.03 (0.96,1.11) | 0.38 |
Male sex | 1.92 (0.09,42.5) | 0.68 | |||
Telemedicine group | 2.44 (0.45,13.2) | 0.3 | |||
Number of visits in year prior to study | 0.42 (0.18,0.98) | 0.04 | |||
Functional status assessment documentation | Multivariate logistic regression | 217 visits | Age, linear | 1.00 (0.97,1.03) | 0.85 |
Male sex | 1.40 (0.60,3.2) | 0.44 | |||
Telemedicine group | 1.48 (0.75,2.90) | 0.26 | |||
High rheumatologist telemedicine rate | 0.04 (0.01,0.20) | <0.001* | |||
Number of visits in year prior to study | 1.30 (1.04,1.62) | 0.02* | |||
DMARD prescribed in past year | Multivariate logistic regression | 122 | Age, linear | 1.27 (1.03,1.55) | 0.02 |
Male sex | 0.06 (0.002,1.72) | 0.1 | |||
Telemedicine group | 1.04 (0.05,21.3) | 0.98 |
CI: Confidence Interval; DMARD: disease-modifying anti-rheumatic drug